ArticleJournal for immunotherapy of cancer2023

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.

Casey R Ager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.